Author: OurCrowd

[Babson Diagnostics in BusinessWire] Babson Diagnostics Named Fierce MedTech “Fierce 15” Company

Mar 9, 2021 |

AUSTIN, Texas–(BUSINESS WIRE)–Babson Diagnostics (Babson), a transformative medical technology company improving customer access to diagnostic blood testing, was named one of Fierce Medtech’s elite “Fierce 15.” The honor recognizes Babson as one of the most promising private companies in the global healthcare industry. In the year of COVID-19, Fierce Medtech, a leading daily digital news publication, examined how med tech companies are addressing the most pressing public health challenges. Read...

Read More

[Tortuga Logic in PR Newswire] Tortuga Logic Announces Expansion of Product Portfolio with Development of New Security Governance Platform

Mar 9, 2021 |

SAN JOSE, Calif., March 9, 2021 /PRNewswire/ — Tortuga Logic® Inc, a cybersecurity company that has pioneered semiconductor chip security solutions, today announced the development of a Security Governance Platform (SGP), expanding its portfolio of advanced hardware security solutions. This effort is bolstered through a recent investment from In-Q-Tel, Inc., an independent, non-profit strategic investor that identifies and accelerates the development of cutting-edge technologies to support the national security community. Read...

Read More

[Biolojic in PR Newswire] Lilly and Biolojic Design Announce Research Collaboration to Discover and Develop Antibody Therapies for Diabetes

Mar 8, 2021 |

INDIANAPOLIS and TEL AVIV, March 8, 2021 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Biolojic Design Ltd. (“Biolojic”), a biotechnology company that computationally designs functional antibodies, today announced a research collaboration and license agreement that will leverage Biolojic’s AI-based multibody platform to discover and develop a potential novel antibody-based therapy for the treatment of diabetes. Read...

Read More